Search for: "Abbott v. Abbott" Results 2041 - 2060 of 2,301
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 May 2010, 12:27 pm by Bexis
Abbott Laboratories, 2009 WL 2231701 (S.D.N.Y. [read post]
15 Jan 2008, 3:06 am
filed 03/22/07 1:07-cv-01721 Abbott Laboratories et al v. [read post]
15 Dec 2010, 2:17 am by Kelly
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not patentable… [read post]
13 Dec 2016, 4:00 am by David Cheifetz
  Wise v Abbott Laboratories, Limited, 2016 ONSC 7275 (CanLII)   This case raises the issue – NOT THE PROBLEM – of keeping current with the spate of decisions constantly being released, even in one’s own jurisdiction, of arguably relevant decisions that are released between the time argument ends and the reasons in the lawyers’ own case are released. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) – US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O)   General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP… [read post]
11 Nov 2009, 6:05 am by Maxwell Kennerly
Abbott, 574 F.3d 203, 206 (3d Cir. 2009) (“As in all cases of statutory interpretation, our inquiry begins with the language of the statute and focuses on Congress' intent. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]